Macpherson Ciara, Stoumpos Sokratis, Geddes Colin C
Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.
J Vasc Access. 2025 Jul;26(4):1224-1228. doi: 10.1177/11297298241264855. Epub 2024 Aug 3.
Catheter related thrombosis is a common complication of tunnelled central venous catheter (TCVC) usage. There are concerns that TCVC removal could dislodge a thrombus to cause pulmonary thromboembolism (PE). The incidence of PE following TCVC removal is unclear and so the aim of this study was to investigate the incidence of PE and whether it is high enough to warrant screening with ultrasound with a view to systemic anticoagulation prior to TCVC removal.
1102 consecutive TCVC removals without ultrasound and systemic anticoagulation were included in this retrospective study. Data were extracted from electronic health records. Measures to identify PE events included: deaths, computed tomography pulmonary angiogram (CT-PA), isotope lung perfusion scans and D-dimers blood tests within 7 days of removal.
Of the 1102 TCVC removals, the mean age of patients was 56.9 years and 57.3% were male. The primary renal diagnosis for 24.5% of patients was diabetic nephropathy. There were seven deaths following removal, none of which had PE as a contributing cause on review of their clinical history and death certificates. Five CT-PAs and one isotope lung perfusion scan were carried out in the 7 days after TCVC removal and none had a positive finding of PE. Three patient had D-dimers measured in blood within 7 days and none of these patients were subsequently diagnosed with PE.
There was no evidence of fatal or non-fatal PE's occurring in the 7 days following TCVC removal. This would support the practice of removing TCVCs without the need for ultrasound screening and without a period of systemic anticoagulation.
导管相关血栓形成是隧道式中心静脉导管(TCVC)使用过程中的常见并发症。有人担心拔除TCVC可能会使血栓脱落,从而导致肺血栓栓塞症(PE)。拔除TCVC后发生PE的发生率尚不清楚,因此本研究的目的是调查PE的发生率,以及该发生率是否高到足以保证在拔除TCVC前进行超声筛查并考虑全身抗凝。
本回顾性研究纳入了1102例连续拔除的未进行超声检查和全身抗凝的TCVC。数据从电子健康记录中提取。识别PE事件的措施包括:拔除后7天内的死亡情况、计算机断层扫描肺动脉造影(CT-PA)、同位素肺灌注扫描和D-二聚体血液检测。
在1102例TCVC拔除病例中,患者的平均年龄为56.9岁,男性占57.3%。24.5%患者的主要肾脏诊断为糖尿病肾病。拔除后有7例死亡,经审查其临床病史和死亡证明,均无PE作为促成死因。在拔除TCVC后的7天内进行了5次CT-PA和1次同位素肺灌注扫描,均未发现PE阳性结果。3例患者在7天内进行了血液D-二聚体检测,这些患者随后均未被诊断为PE。
没有证据表明在拔除TCVC后的7天内发生了致命或非致命性PE。这将支持在无需超声筛查和全身抗凝期的情况下拔除TCVC的做法。